United Kingdom · Question · Written question
UIN 9822
Hydrocortisone
Introduced
15 June 2026
Last action
25 June 2026 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
25 June 2026
Summary
To ask the Secretary of State for Health and Social Care, if he will work with Pfizer to accelerate the UK licensing of the ‘ACT-O-VIAL’ dual-compartment hydrocortisone product containing pre-measured doses of powder and water for immediate mixing.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
15 June 2026
Written question
To ask the Secretary of State for Health and Social Care, if he will work with Pfizer to accelerate the UK licensing of the ‘ACT-O-VIAL’ dual-compartment hydrocortisone product containing pre-measured doses of powder and water for immediate mixing.
Source: Commons
25 June 2026
Answer
The Department is aware of the discontinuation of hydrocortisone sodium phosphate 100 milligram/1 millilitre solution for injection, and we continue to work with industry to find a longer-term solution.Hydrocortisone sodium succinate 100 milligram powder ...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2026-06-15/9822
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1916087
- uk · wq-1916087 · source updated 25 June 2026